GGrantIndex
← Search

ALENDRONATE IN POSTMENOPAUSAL, OSTEOPOROTIC WOMEN, FIT EXTENSION STUDY

$22,028M01FY2000RRNIH

University Of Iowa, Iowa City IA

Investigators

Linked publications & trials

Abstract

This study is determining if subjects who participated in the Fracture Intervention Trial and received alendronate for 3 to 6 years have preserved or increased total hip bone mineral density with an additional 5 years of therapy compared to placebo in osteoporotic postmenopausal women.

View original record on NIH RePORTER →